My Blog List

Monday, 15 January 2018

United States Remicade Biosimilar Market and Industry Analysis Report 2018



Description:

In this report, the United States Remicade Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Remicade Biosimilar in these regions, from 2012 to 2022 (forecast).


United States Remicade Biosimilar market competition by top manufacturers/players, with Remicade Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva Pharmaceutical Industries
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
100mg/10ml
500mg/50ml
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Blood Disorders
Oncology Diseases

For any enquires before buying, connect with us @ https://www.reporthive.com/enquiry.php?id=1270876&req_type=disc

Table of Content:

1 Remicade Biosimilar Overview1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Classification of Remicade Biosimilar by Product Category
1.2.1 United States Remicade Biosimilar Market Size (Sales Volume) Comparison by Type (2012–2022)
1.2.2 United States Remicade Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 100mg/10ml
1.2.4 500mg/50ml
1.3 United States Remicade Biosimilar Market by Application/End Users
1.3.1 United States Remicade Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2012–2022)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 United States Remicade Biosimilar Market by Region
1.4.1 United States Remicade Biosimilar Market Size (Value) Comparison by Region (2012–2022)
1.4.2 The West Remicade Biosimilar Status and Prospect (2012–2022)
1.4.3 Southwest Remicade Biosimilar Status and Prospect (2012–2022)
1.4.4 The Middle Atlantic Remicade Biosimilar Status and Prospect (2012–2022)
1.4.5 New England Remicade Biosimilar Status and Prospect (2012–2022)
1.4.6 The South Remicade Biosimilar Status and Prospect (2012–2022)
1.4.7 The Midwest Remicade Biosimilar Status and Prospect (2012–2022)
1.5 United States Market Size (Value and Volume) of Remicade Biosimilar (2012–2022)
1.5.1 United States Remicade Biosimilar Sales and Growth Rate (2012–2022)
1.5.2 United States Remicade Biosimilar Revenue and Growth Rate (2012–2022)

2 United States Remicade Biosimilar Market Competition by Players/Suppliers2.1 United States Remicade Biosimilar Sales and Market Share of Key Players/Suppliers (2012–2017)
2.2 United States Remicade Biosimilar Revenue and Share by Players/Suppliers (2012–2017)
2.3 United States Remicade Biosimilar Average Price by Players/Suppliers (2012–2017)
2.4 United States Remicade Biosimilar Market Competitive Situation and Trends
2.4.1 United States Remicade Biosimilar Market Concentration Rate
2.4.2 United States Remicade Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Remicade Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India